• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Adrenal scintigraphy in primary aldosteronism. Spironolactone as a cause of incorrect classification between adenoma and hyperplasia.

作者信息

Fischer M, Vetter W, Winterg B, Zidek W, Vetter H

出版信息

Eur J Nucl Med. 1982;7(5):222-4. doi: 10.1007/BF00256468.

DOI:10.1007/BF00256468
PMID:7094925
Abstract

In primary aldosteronism the type of adrenal lesion was correctly identified in 28 of 40 patients (70%) by standard adrenal scintigraphy. Suppression scintigraphy did not improve the validity of the method. In all patients the diagnosis was confirmed by surgery (unilateral adenoma n = 32; bilateral adrenal hyperplasia n = 11). False classification of the adrenal lesion(s) by standard scintigraphy was mostly due to a bilateral adrenal isotopic uptake in patients with an unilateral aldosteronoma. However, a substantial number of these patients (6 of 11 patients) received long-term spironolactone treatment prior to the examination. Thus, in primary aldosteronism adrenal changes induced by chronic spironolactone administration are probably a major cause for incorrect differentiation between adenoma and hyperplasia by adrenal scintigraphy.

摘要

相似文献

1
Adrenal scintigraphy in primary aldosteronism. Spironolactone as a cause of incorrect classification between adenoma and hyperplasia.
Eur J Nucl Med. 1982;7(5):222-4. doi: 10.1007/BF00256468.
2
Scintigraphic localization of adrenal lesions in primary aldosteronism.
Am J Med. 1984 Nov;77(5):839-44. doi: 10.1016/0002-9343(84)90521-7.
3
[The role of adrenal gland x-ray computed tomography and scintigraphy using radiolabelled norcholesterol in the etiological diagnosis of primary hyperaldosteronism].[肾上腺X线计算机断层扫描及使用放射性标记去甲胆固醇的闪烁扫描术在原发性醛固酮增多症病因诊断中的作用]
Rev Med Interne. 1993;14(7):691-7. doi: 10.1016/s0248-8663(05)81234-2.
4
[Computer tomographic localisation in primary aldosteronism. Comparison with adrenal scintigraphy (author's transl)].原发性醛固酮增多症的计算机断层扫描定位。与肾上腺闪烁扫描术的比较(作者译)
Rofo. 1980 Dec;133(6):629-33. doi: 10.1055/s-2008-1056804.
5
Adrenal scintigraphy in primary aldosteronism. Improved visualization after long-term pre-treatment with dexamethasone.原发性醛固酮增多症中的肾上腺闪烁显像。地塞米松长期预处理后显像改善。
Nuklearmedizin. 1981 Apr;20(2):76-81.
6
Interference by spironolactone on adrenocortical scintigraphy and other pitfalls in the location of adrenal abnormalities in primary aldosteronism.螺内酯对肾上腺皮质闪烁扫描的干扰及原发性醛固酮增多症肾上腺异常定位中的其他陷阱。
Clin Nucl Med. 1994 May;19(5):441-5. doi: 10.1097/00003072-199405000-00015.
7
Adrenal imaging with iodomethyl-norcholesterol (I-131) in primary aldosteronism.原发性醛固酮增多症中使用碘甲基去甲胆固醇(I-131)进行肾上腺成像。
J Nucl Med. 1979 Aug;20(8):897-8.
8
[Adrenal cortex scintigraphy with and without dexamethasone suppression in the study of primary aldosteronism].
Rev Esp Med Nucl. 2004 Sep-Oct;23(5):324-9. doi: 10.1016/s0212-6982(04)72311-3.
9
131I-iodocholesterol (NP-59) scintigraphy in adrenocortical diseases.131I-碘胆固醇(NP-59)闪烁扫描术在肾上腺皮质疾病中的应用
J Can Assoc Radiol. 1983 Jun;34(2):120-4.
10
[Iodo-methyl norcholesterol scintigraphy in the localization of primary hyperaldosteronism].
Arch Mal Coeur Vaiss. 1989 Jul;82(7):1233-5.

引用本文的文献

1
Drug interactions with radiopharmaceuticals.药物与放射性药物的相互作用。
Eur J Nucl Med. 1994 Apr;21(4):348-56. doi: 10.1007/BF00947972.

本文引用的文献

1
Lateralization procedures in primary aldosteronism.原发性醛固酮增多症的侧别定位程序
Klin Wochenschr. 1980 Oct 15;58(20):1135-41. doi: 10.1007/BF01477235.
2
Effect of spironolactone on aldosterone regulation in man.螺内酯对人体醛固酮调节的作用。
Clin Sci (Lond). 1980 Mar;58(3):227-33. doi: 10.1042/cs0580227.
3
131 I-19-iodocholesterol in the diagnosis of adrenal disease.
J Lab Clin Med. 1971 Dec;78(6):986-7.
4
Reduced aldosterone secretion during spironolactone treatment in primary aldosteronism: report of a case.原发性醛固酮增多症患者螺内酯治疗期间醛固酮分泌减少:一例报告
J Clin Endocrinol Metab. 1974 Oct;39(4):734-9. doi: 10.1210/jcem-39-4-734.
5
Fine structure and morphogenesis of spironolactone bodies in the zona glomerulosa of the human adrenal cortex.人肾上腺皮质球状带中螺内酯体的精细结构与形态发生
J Clin Pathol. 1973 Dec;26(12):949-57. doi: 10.1136/jcp.26.12.949.
6
Spironolactone-induced inhibition of aldosterone biosynthesis in primary aldosteronism: morphological and functional studies.
Metabolism. 1977 Dec;26(12):1293-307. doi: 10.1016/0026-0495(77)90026-9.
7
Effect of a spirolactone on plasma and urinary aldosterone in primary aldosteronism.
Horm Res. 1977;8(1):23-8. doi: 10.1159/000178776.
8
Effects in animals of chronic administration of spironolactone--a review.慢性给予螺内酯对动物的影响——综述
J Environ Pathol Toxicol. 1978 May-Jun;1(5):641-60.
9
Primary aldosteronism: diagnosis, localization, and treatment.
Ann Intern Med. 1979 Mar;90(3):386-95. doi: 10.7326/0003-4819-90-3-386.
10
Control of plasma aldosterone in a patient with Conn's syndrome before and during spironolactone medication.原发性醛固酮增多症患者在服用螺内酯之前及期间血浆醛固酮的控制情况。
Klin Wochenschr. 1975 Apr 15;53(8):391-3. doi: 10.1007/BF01468678.